Primary cutaneous indolent B-cell lymphomas – a retrospective multicenter analysis and a review of literature

References

• Willemze R, Cerroni L, Kempf W, et al. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood. 2019;133(16):1703–1714.
   PubMed Web of Science ®Google Scholar
• Nicolay JP, Wobser M. Cutaneous B-cell lymphomas – pathogenesis, diagnostic workup, and therapy. J Dtsch Dermatol Ges. 2016;14(12):1207–1224.
   Web of Science ®Google Scholar
• Lima M. Cutaneous primary B-cell lymphomas: from diagnosis to treatment. An Bras Dermatol. 2015;90(5):687–706.
   PubMed Web of Science ®Google Scholar
• Wilcox RA. Cutaneous B-cell lymphomas: 2019 update on diagnosis, risk stratification, and management. Am J Hematol. 2018;93(11):1427–1430.
   PubMed Web of Science ®Google Scholar
• Jaffe ES. Navigating the cutaneous B-cell lymphomas: avoiding the rocky shoals. Mod Pathol. 2020;33(Suppl 1):96–106.
   PubMed Web of Science ®Google Scholar
• Servitje O, Climent F, Colomo L, et al. Primary cutaneous vs secondary cutaneous follicular lymphomas: a comparative study focused on BCL2, CD10, and t(14;18) expression. J Cutan Pathol. 2019;46(3):182–189.
   PubMed Web of Science ®Google Scholar
• Senff NJ, Noordijk EM, Kim YH, et al. European Organization for Research and Treatment of Cancer; International Society for Cutaneous Lymphoma. European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas. Blood. 2008;112(5):1600–1609.
   PubMed Web of Science ®Google Scholar
• Hoefnagel JJ, Vermeer MH, Jansen PM, et al. Primary cutaneous marginal zone B-cell lymphoma: clinical and therapeutic features in 50 cases. Arch Dermatol. 2005;141(9):1139–1145.
   PubMedGoogle Scholar
• Lucioni M, Berti E, Arcaini L, et al. Primary cutaneous B-cell lymphoma other than marginal zone: clinicopathologic analysis of 161 cases: comparison with current classification and definition of prognostic markers. Cancer Med. 2016;5(10):2740–2755.
   PubMed Web of Science ®Google Scholar
• de la Fouchardiere A, Balme B, Chouvet B, et al. Pathological and clinical correlations in primary cutaneous B-cell lymphomas: a series of 44 cases. Ann Pathol. 2005;25(1):8–17.
   PubMed Web of Science ®Google Scholar
• Senff NJ, Hoefnagel JJ, Jansen PM, et al. Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers. J Clin Oncol. 2007;25(12):1581–1587.
   PubMed Web of Science ®Google Scholar
• Kim YH, Willemze R, Pimpinelli N, et al. ISCL and the EORTC. TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC). Blood. 2007;110(2):479–484.
   PubMed Web of Science ®Google Scholar
• Kheterpal MK, Dai J, Geller S, et al. Role of imaging in low-grade cutaneous B-cell lymphoma presenting in the skin. J Am Acad Dermatol. 2019;81(4):970–976.
   PubMed Web of Science ®Google Scholar
• Mirza I, Macpherson N, Paproski S, et al. Primary cutaneous follicular lymphoma: an assessment of clinical, histopathologic, immunophenotypic, and molecular features. J Clin Oncol. 2002;20(3):647–655.
   PubMed Web of Science ®Google Scholar
• Abdul-Wahab A, Tang SY, Robson A, et al. Chromosomal anomalies in primary cutaneous follicle center cell lymphoma do not portend a poor prognosis. J Am Acad Dermatol. 2014;70(6):1010–1020.
   PubMed Web of Science ®Google Scholar
• Streubel B, Scheucher B, Valencak J, et al. Molecular cytogenetic evidence of t(14;18)(IGH;BCL2) in a substantial proportion of primary cutaneous follicle center lymphomas. Am J Surg Pathol. 2006;30(4):529–536.
   PubMed Web of Science ®Google Scholar
• Bergman R, Kurtin PJ, Gibson LE, et al. Clinicopathologic, immunophenotypic, and molecular characterization of primary cutaneous follicular B-cell lymphoma. Arch Dermatol. 2001;132(4):432–439.
   Google Scholar
• Golling P, Cozzio A, Dummer R, et al. Primary cutaneous B-cell lymphomas – clinicopathological, prognostic and therapeutic characterisation of 54 cases according to the WHO-EORTC classification and the ISCL/EORTC TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome. Leuk Lymphoma. 2008;49(6):1094–1103.
   PubMed Web of Science ®Google Scholar
• Hamilton SN, Wai ES, Tan K, et al. Treatment and outcomes in patients with primary cutaneous B-cell lymphoma: the BC Cancer Agency experience. Int J Radiat Oncol Biol Phys. 2013;87(4):719–725.
   PubMed Web of Science ®Google Scholar
• Valencak J, Weihsengruber F, Rappersberger K, et al. Rituximab monotherapy for primary cutaneous B-cell lymphoma: response and follow-up in 16 patients. Ann Oncol. 2009;20(2):326–330.
   PubMed Web of Science ®Google Scholar
• Akhtari M, Reddy JR, Pinnix CC, et al. Primary cutaneous B-cell lymphoma (non-leg type) has excellent outcomes even after very low dose radiation as single-modality therapy. Leuk Lymphoma. 2016;57(1):34–38.
   PubMed Web of Science ®Google Scholar
• Goyal A, Carter JB, Pashtan I, et al. Very low-dose versus standard dose radiation therapy for indolent primary cutaneous B-cell lymphomas: a retrospective study. J Am Acad Dermatol. 2018;78(2):408–410.
   PubMed Web of Science ®Google Scholar
• Oertel M, Elsayad K, Weishaupt C, et al. De-escalated radiotherapy for indolent primary cutaneous B-cell lymphoma. Strahlenther Onkol. 2020;196(2):126–131.
   PubMed Web of Science ®Google Scholar
• Suárez AL, Querfeld C, Horwitz S, et al. Primary cutaneous B-cell lymphomas: part II. Therapy and future directions. J Am Acad Dermatol. 2013;69(3):343.e1.
   PubMed Web of Science ®Google Scholar
• Muniesa C, Domingo-Domenech E, Fornons-Servent R, et al. Systemic rituximab for the treatment of the indolent forms of primary cutaneous B-cell lymphomas: data from the Spanish Primary Cutaneous Lymphoma Registry. J Am Acad Dermatol. 2020;83(5):1535–1538.
   PubMed Web of Science ®Google Scholar